Agios Pharmaceuticals reported $16.19M in Stock for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Abbvie ABBV:US $ 3483M 355M
Alnylam Pharmaceuticals ALNY:US $ 78.52M 44.18M
Amgen AMGN:US $ 4411M 325M
Astellas Pharma 4503:JP Y 153072M 1496M
Bayer BAYN:GR € 10869M 445M
Biogen BIIB:US $ 1215.4M 136.1M
Biomarin Pharmaceutical BMRN:US $ 786.36M 9.69M
Bristol Myers Squibb BMY:US $ 2104M 9M
Daiichi Sankyo 4568:JP Y 217910M 6304M
Eli Lilly And LLY:US $ 3893M 7M
Exelixis EXEL:US $ 28.47M 0.97M
Gilead Sciences GILD:US $ 2675M 1057M
GlaxoSmithKline GSK:LN 6003M 220M
JAZZ PHA JAZZ:US $ 985.45M 87.27M
Merk MRK:US $ 5774M 179M
Moderna Inc MRNA:US 1.94B 501M
Nektar Therapeutics NKTR:US $ 15.38M 0.42M
Novartis NOVN:VX SF 6997M 331M
Pfizer PFE:US $ 9979M 920M
Puma Biotechnology PBYI:US $ 7.28M 0.17M
Regeneron Pharmaceuticals REGN:US $ 1991.5M 488.7M
Sarepta Therapeutics SRPT:US $ 199M 12.78M
Seattle Genetics SGEN:US $ 275.75M 75.08M
Vertex Pharmaceuticals VRTX:US $ 338.9M 14.2M
YTE INCY:US $ 35.46M 7.55M